D.A. Davidson & Co. Lexicon Pharmaceuticals, Inc. Transaction History

D.A. Davidson & Co.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 05, 2020	SELL	$1.8 - $4.28 $42,390 - $100,794	-23,550 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.16 - $5.15 $8,816 - $14,368	2,790 Added 13.44%	23,550 $98,000
Q3 2019 Nov 05, 2019	SELL	$1.2 - $6.66 $3,360 - $18,648	-2,800 Reduced 11.88%	20,760 $62,000
Q2 2019 Aug 13, 2019	BUY	$5.35 - $7.11 $10,833 - $14,397	2,025 Added 9.4%	23,560 $148,000
Q1 2019 May 13, 2019	BUY	$4.36 - $7.94 $36,863 - $67,132	8,455 Added 64.64%	21,535 $120,000
Q4 2018 Jan 29, 2019	BUY	$6.15 - $10.51 $80,442 - $137,470	13,080 New	13,080 $87,000
Q3 2017 Nov 08, 2017	SELL	$12.17 - $16.3 $55,982 - $74,980	-4,600 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	4,600	4,600 $0

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

Stay updated on D.A. Davidson & Co. with notifications on news.